Tilray | TRLY - Efectivo Y Equivalentes

Precio De Mercado
8.96
Cambio Diario
-0.44 -4.68%
Mensual
7.31%
Anual
1,237.31%
Q2 Expectativa
9.04




Efectivo Y Equivalentes Cambio Fecha
Acasti Pharma USD 16.86M 3.14M 2025-09
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alaunos Therapeutics USD 1.94M 941K 2025-09
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Avita Medical AUD 10.24M 1.98M 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Cronos Group USD 791.79M 7.62M 2025-12
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Moderna USD 2.6B 1.46B 2025-12
Organigram Holdings CAD 7.58M 20.62M 2025-12
Organon & Co USD 672M 73M 2025-09
Revvity USD 919.86M 11.53M 2025-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 1.32B 347.1M 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12